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Abstract
The prokaryotic adaptive immune system CRISPR/Cas9 has recently been adapted for genome editing in eukaryotic cells.
This technique allows for sequence-specific induction of double-strand breaks in genomic DNA of individual cells, effectively
resulting in knock-out of targeted genes. It thus promises to be an ideal candidate for application in neuroscience where
constitutive genetic modifications are frequently either lethal or ineffective due to adaptive changes of the brain. Here we
use CRISPR/Cas9 to knock-out Grin1, the gene encoding the obligatory NMDA receptor subunit protein GluN1, in a sparse
population of mouse pyramidal neurons. Within this genetically mosaic tissue, manipulated cells lack synaptic current
mediated by NMDA-type glutamate receptors consistent with complete knock-out of the targeted gene. Our results show
the first proof-of-principle demonstration of CRISPR/Cas9-mediated knock-down in neurons in vivo, where it can be a useful
tool to study the function of specific proteins in neuronal circuits.
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Introduction
The typical approach to investigate the function of a given
protein is to delete the genomic sequence encoding it and study the
physiological effect of this ‘knock-out’ [1]. In neuroscience this
approach has been used widely, but results are often limited by
several technical difficulties. First, a significant subset of genes is
essential for survival, and genomic deletion is lethal [2]. Second,
the plasticity of the brain can lead to developmental compensation
for deleted genes, thereby obscuring the effect [3]. These problems
have been circumvented by generating conditional knock-out
mice, in which genomic deletion of a gene depends on the
presence of a recombinase whose expression can be spatially and/
or temporally restricted [4]. However, this approach still requires
the generation of germline genetically modified mice, a process
that takes at least several months.
The difficulties of conventional transgenic mouse models could
be overcome by efficient genome editing methods that would allow
controlled perturbation in post-mitotic neurons. The type II
prokaryotic adaptive immune system (clustered regularly inter-
spaced short palindromic repeats (CRISPR)) [5] with the
endonuclease CRISPR-associated (Cas) 9 has recently been
engineered for this use in mammalian cells [6,7]. In addition to
the endonuclease Cas9, CRISPR/Cas9-mediated editing requires
two short RNAs, a target-recognizing CRISPR-RNA, and a Cas9-
recruiting tracer-RNA; both RNAs can be linked together as single
guide-RNA (gRNA) [8]. When co-expressed with an appropriate
gRNA, Cas9 is recruited to the genomic DNA in a sequence-
specific manner, and cuts both strands at a precise location. The
genomic DNA is then repaired by non-homologous end joining
(NHEJ), introducing mutations that effectively interrupt the open
reading frame, and thereby results in a functional knock-out of the
encoded protein [8].
Since its first application in mammalian cells, CRISPR/Cas9
has been used in many different organisms and applications [9–
15]; however, it is still unknown if this system can be used in
mammalian neurons to generate genetically mosaic brain tissue.
Here we demonstrate that CRISP/Cas9-mediated knock-down
can be used to effectively delete proteins in individual post-mitotic
neurons of an otherwise unperturbed brain.
Materials and Methods
Animal research and ethics statement
All experiments that included animals were carried out in
accordance with protocols approved by the Harvard Standing
Committee on Animal Care following guidelines described in the
US National Institutes of Health Guide for the Care and Use of
Laboratory Animals, and all efforts were made to minimize
suffering. For in-utero electroporation, mice were anesthetized
using 2% isoflurane and injected with 0.1 mg/kg of buprenorphr-
ine as anesthetic. For euthanasia, mice were anesthetized with
isoflurane. This study, and all procedures in it, was approved by
the Harvard Medical School Institutional Animal Care and Use
Committee (IACUC), protocol no. 03551.
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The genomic sequence surrounding the sequence encoding for
the second transmembrane region of mouse GluN1 (6200 bp) was
analyzed for potential CRISPR/Cas9 targets in silico [16]. The
two sequences with the highest predicted ‘on-target score’,
‘CRISPR/Cas9 against Grin1.1/2’ (‘CC_Grin1.1’ and
‘CC_Grin1.2’, Figure 1B) were synthesized and subcloned into a
vector (pX330, addgene plasmid #42230) containing the flanking
gRNA sequences and a codon-optimized Cas9 [8].
In-utero electroporations
Neuronal transfections were performed by in-utero electropo-
ration of E15 wild-type C57BL/6J mice as described previously
[17]. Briefly, an E15 pregnant mother was anesthetized using 2%
isoflurane and injected with 0.1 mg/kg of buprenorphrine as
anesthetic. Embryonic pups within the intact uterus were
temporarily removed from the abdomen and injected into the
left hemisphere with 1 ml of DNA mixture, containing the
appropriate CRISPR-construct and soluble GFP (10:1), using a
,50 mm-diameter pipette sharply beveled at 15u–20u (Narishige,
Japan), visually confirming the proper site of correct injection by
mixing 0.005% fast green with the DNA. To target transfection to
the hippocampus, the head of the embryonic pup was placed
between paddles of tweezer electrodes (CUY21 electroporator,
NEPA GENE, Japan), with the positive terminal covering the
lateral surface of the right hemisphere and the negative terminal
covering the left hemisphere. Each injected embryo was then
subjected to 5650 ms/35 V electric pulses. Following electropo-
ration, the intact uterus containing the pups was returned to the
abdomen, and the mother’s abdomen sutured shut. Recordings
were made from transfected pups 14–20 days following birth.
Biolistic transfection of organotypic slice cultures
Biolistic transfection of post-mitotic neurons was achieved using
organotypic hippocampal slice cultures. Slice cultures were
prepared from P6–8 wild-type Sprague-Dawley rats as described
previously [18]. Slice cultures were maintained at 34uC with 5%
CO2 on 30 mm Millicell Cell Culture inserts with 0.4 um pores
Figure 1. CRISPR/Cas9 mediated knock-down of NMDA receptors. (A) Schematic domain organization of a GluN1 subunit. Red star indicates
location of the CC_Grin1.1 target sequence. Circled N/C indicate N-/C-terminus respectively; NTD: N-terminal binding domain; LBD: ligand binding
domain; roman numbers indicate transmembrane domains 1–3, ec/ic: extracellular/intracellular. (B) Genomic sequences of CRISPR/Cas9 targets in
GluN1. Grin1 (encoding for mouse GluN1) is located on the reverse strand of chromosome 2, and the third transmembrane domain is encoded by
exon 14. Target sequences are underlined, crRNA sequences are in red, PAM sequences in green. Numbers above DNA strand indicate chromosomal
position. (C) Example traces of AMPAR currents (recorded at 270 mV, inward) and NMDAR currents (recorded at +40 mV, outward) from acute brain
slices. From left to right: untransfected, pX330 (‘empty’ CRISPR/Cas9 without targeting sequence), CC_Grin1.1, CC_Grin1.2. Scale bars are 50 pA and
100 ms. (D) NMDAR/AMPAR current ratio for all cells. Untransfected control cells were interleaved with neighboring GFP-positive experimental cells.
AMPAR current amplitude was measured as the peak inward current at 270 mV, while NMDAR current amplitude was measured 100 msec after
stimulation at +40 mV, to avoid contamination with AMPARs. Bars indicate mean 6 S.E.M., grey circles individual cells. Transfection with CC_Grin1.1
completely eliminated NMDAR currents (Kruskall-Wallis test, followed by Dunn’s test).
doi:10.1371/journal.pone.0105584.g001
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20% heat-inactivated horse serum, 1 mM L-glutamine, 1 mM
CaCl2, 2 mM MgCl2, insulin (1 mg/l), 13 mM D-Glucose,
5.2 mM NaHCO3, 30 mM HEPES, and 0.00125% ascorbic acid.
Media was changed every 2–3 days. For biolistic transfection, a
DNA mixture containing 50 mg of the CRISPR-construct and
30 mg of a GFP-expressing plasmid were precipitated onto 1 mm
diameter gold particles, washed with ethanol, and coated onto the
inside of Tefzel tubing (Bio-rad). After 2–3 days in vitro, slice
cultures were shot with the DNA-coated gold cartridges using 100
PSI ultra-pure helium with a Helios GeneGun (BioRad).
Transfected neurons were identified by the presence of both
GFP epifluorescence and a gold particle in the neuronal cell body.
Neurons that were GFP positive, but lacking a gold particle or
visibly fused with neighboring cells were excluded from analysis.
Electrophysiology
Whole-cell voltage clamp recordings were obtained from
transfected hippocampal CA1 and CA3 pyramidal neurons as
identified by GFP epifluorescence, as well as neighboring
untransfected control cells. Initial target sequence validation was
performed in neurons transfected via in utero electroporation.
Transfected CA1 and CA3 neurons were recorded from 300 mm
acute, horizontal brain slices of P14–20 mice, cut using a
vibratome (Leica Biosystems) in a chilled sucrose cut solution
containing (in mM): 2.5 KCl, 7 MgSO4, 1.25 NaH2PO4,2 5
NaHCO3, 7 glucose, 210 sucrose, 1.3 ascorbic acid, and 3 sodium
pyruvate. Following cutting, the slices recovered for 30 minutes in
34uC artificial cerebral spinal fluid (ACSF) containing (in mM):
119 NaCl, 2.5 KCl, 1 NaH2PO4, 26.2 NaHCO3, 11 glucose, 2.5
CaCl2, and 1.3 MgCl2. Both the cut solution and ACSF were
bubbled with 95% O2/5% CO2 gas throughout dissection, slicing
and recording. During recording, slices were perfused at a rate of
250 ml/hr with ACSF. 10 mM SR 95531 (Tocris) was added to
the ACSF to block inhibition. For recordings from organotypic
slice cultures, CaCl2 and MgCl2 concentration were both
increased to 4 mM and 10 mM 2-chloroadensine (Tocris) added
to prevent runaway excitation following stimulation. Synaptic
responses were evoked using electrical stimulation of stratum
radiatum from a tungsten bipolar electrode (FHC). To minimize
polysynaptic responses, a cut was made at the border of CA3 and
CA1 using a microscalpel (Electron Microscopy Sciences). Whole-
cell recordings were made using 3–5 MV glass pipettes filled with
internal solution containing (in mM): 135 CsMeSO4, 8 NaCl,
10 HEPES, 0.3 EGTA, 5 QX-314, 4 Mg-ATP, 0.3 Na-GTP, and
0.1 spermine, at 294 mOsm and pH 7.34. Whole-cell voltage
clamp was performed using a Multiclamp 700B amplifier (Axon
instruments) with a 3 kHz Bessel filter, digitized at 10 kHz using a
National Instruments data acquisition board, and recorded using
custom-written MatLab (MathWorks) software [19].
Data analysis and statistics
Data were analyzed offline in Igor Pro (Wavemetrics). For each
cell the average peak response at 270 mV holding potential was
quantified from 10–20 sweeps as AMPAR mediated current,
whereas an equal number of recordings at +40 mV where
quantified at 100 ms post-stimulus as NMDAR current. These
two values were used to calculate the NMDA/AMPA ratio, and
for each cell the holding potential was switched several times back
and forth during the recording, to account for potential changes in
the evoked response over time. Different conditions were
compared using non-parametric statistical tests, Mann-Whitney
test for two groups and Kruskal–Wallis analysis of variance
(ANOVA) followed by Dunn’s Multiple Comparison Test for
multiple group comparisons.
Figure 2. CRISPR/Cas9-mediated knock-down in postmitotic neurons. (A) Example traces of AMPAR currents (recorded at 270 mV, inward)
and NMDAR currents (recorded at +40 mV, outward) from organotypic slice cultures. Shown are examples from untransfected cells and CC_Grin1.1
transfected cells following 10 days expression (left) and 18 days expression (right). Scale bars are 20 pA (left) or 50 pA (right) and 100 ms. (B) NMDAR/
AMPAR current ratio for all cells as described before. Untransfected and CC_Grin1.1 transfected cells were compared individually for different time
points, using the Mann-Whitney test.
doi:10.1371/journal.pone.0105584.g002
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To test CRISPR/Cas9-mediated gene knockout in post-mitotic
mouse neurons, we targeted Grin1, the gene encoding the GluN1
subunit of the N-methyl-D-aspartate-type glutamate receptor
(NMDAR). This subunit is essential for NMDAR function [20],
and the degree of GluN1 loss can be easily assayed by the
amplitude of synaptic NMDAR currents [21]. Additionally,
constitutive genomic deletion of Grin1 is embryonic lethal [22],
whereas a hypomorphic allele shows decreased NMDAR currents
and severe neural dysfunction early in development [18]. A
conditional GluN1 knockout mouse has been generated [23], and
sparse transfection of Cre has been used to examine the effect of
NMDAR deletion in individual hippocampal neurons [24,25].
Thus, targeting GluN1 provides a well-characterized and robust
experimental system to assay for the deletion of an essential
protein in individual neurons of an otherwise unperturbed brain.
We identified two genomic CRISPR/Cas9 target sequences (see
methods) within or near the region encoding for the second, pore-
forming transmembrane domain of GluN1 (Figure 1A, B).
‘CC_Grin1.1’ is located on the sense strand of exon 14, spanning
the sequence that encodes the beginning of the second
transmembrane domain; ‘CC_Grin1.2’ is on the intron anti-sense
strand between exon 13 and 14, about 130 bp upstream of
CC_Grin1.1. The appropriate sequences were subcloned into a
vector containing all other elements required for CRISPR/Cas9
mediated knock-down [8]. Identification of target sequences and
the required cloning required less than three days, emphasizing
the simplicity and effectiveness of this approach.
To functionally assay for NMDAR-deletion, CC_Grin1.1 and
CC_Grin1.2 were transfected by in-utero electroporation into the
hippocampus of wildtype mice, and a plasmid encoding GFP was
co-transfected at a 1:10 ratio. We measured the ratio of NMDAR-
over AMPAR- (a-amino-3-hydroxy-5-methyl-4-isoxazolepropio-
nic acid receptor) mediated currents at CA3 and CA1 pyramidal
neurons (see methods), following electrical stimulation of dentate
gyrus mossy fiber (MF) and CA3 Shaffer collaterals (SC) pathways,
respectively. The ratio of the amplitudes of NMDAR and
AMPAR mediated excitatory postsynaptic currents (EPSCs) in
untransfected pyramidal neurons was 0.6160.04 (n=36), and
transfection of a CRISPR/Cas9 construct lacking the targeting
sequence (‘pX330’) had no effect on this ratio (0.5360.05, n=8).
In contrast, cells transfected with CC_Grin1.1 showed complete
loss of NMDAR currents (0.0460.01, n=12). Importantly, the
functional loss of NMDAR by CC_Grin1.1 was observed in every
cell tested, demonstrating effective CRISPR/Cas9 mediated
knockdown with full penetrance and suggesting disruption of both
genomic alleles. Using the same approach with CC_Grin1.2 did
not show any effect (0.6760.11, n=10), and every cell tested
showed robust NMDAR currents (Figure 1C). Together, the
results demonstrate that CRISP/Cas9-mediated knockdown can
be applied to neurons in vivo. However, since both CC_Grin1.1
and CC_Grin1.2 had similarly high predicted ‘on-target scores’
(94% and 92%, respectively) these results also show that any given
target sequence needs to be confirmed individually.
Acute knockdown in the brain requires genetic modification in
neurons – i.e. in post-mitotic cells. Since in-utero electroporation
functions by transfecting mitotic precursor cells, we repeated our
experiments in organotypic hippocampal slice cultures, where
biolistic transfection occurs in post-mitotic neurons. The slice
cultures were prepared from rat; however, the target sequence of
CC_Grin1.1 is fully conserved between mouse and rat. Following
10 days of expression, CC_Grin1.1 significantly reduced NMDAR
currents compared to untransfected neighboring control cells
(Figure 2, left). However, some cells still showed a small residual
NMDAR current, presumably due to slow turn-over of NMDAR
protein [26]. We therefore repeated the experiment and expressed
CC_Grin1.1 for 18 days, comparable to the expression time in
acute slices following in-utero electroporation. This time window
was enough to eliminate all NMDAR currents in CC_Grin1.1
transfected cells (Figure 2, right). These experiments in organo-
typic hippocampal slice culture demonstrate that complete
CRISPR/Cas9-mediated knock-down can be achieved in acutely
transfected post-mitotic neurons.
Altogether, our results show that the CRISPR/Cas9 system can
be used to abolish proteins of interest from individual cells in the
postnatal brain. The number of cells depends purely on the
transfection efficiency, and this method is therefore ideally suited
to prevent plastic adaption that can obscure knock-down effects. In
comparison to other acute knock-down methods, CRISPR/Cas9-
mediated knock-down is either more efficient and complete (e.g.
RNA-interference based approaches [21]) or faster (generation of
conditional knock-out mice and subsequent transfection with Cre),
making it the ideal candidate for the investigation of neuronal
function.
However, several technical challenges remain to be considered
for use of CRISPR/Cas9 in neurons. A principal concern for the
use of CRISP/Cas9 is that of off-target effects, which can be
expected from a method that relies on a 20 bp recognition motif.
Recent work has begun to address this problem [27,28], and it
remains the biggest challenge for future use of CRISP/Cas9.
Guide RNA target-sequences will therefore not only need to be
screened for efficacy, but selected to attempt to minimize off-target
effects. Another important point for future use of CRISPR/Cas9
in the brain will be the development of effective gene delivery
methods. Both in-utero electroporation and biolistic transfection of
slice cultures allow for delivery of multiple large expression
constructs, but are limited in terms of spatial and temporal
specificity. The required CRISPR/Cas9 sequences are too large to
be packaged into adeno-associated virus, the method of choice for
genetic manipulation of mature neurons in vivo [29], and viral
delivery will have to rely either on a two-virus system, or the use of
alternative viral vectors that tolerate longer extrinsic DNA
sequences, such as lentivirus.
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